Author

Olga Danov

Fraunhofer Institute for Toxicology and Experimental MedicineORCID 0000-0001-6860-5610Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Armin C. BrauniD· 1 shared Danny David JonigkiD· 1 shared Frank NoéiD· 1 shared Heike Hofmann-Winkler· 1 shared Heike Oberwinkler· 1 shared Helen Hilpert· 1 shared Hirotaka Mizuno· 1 shared Jason M. SheltzeriD· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Armin C. BraunORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologyScientific ReportsPeer-reviewedMar 15, 2021

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2

Melissa Zimniak, Luisa Kirschner, Helen Hilpert…·Jochen Bodem

The paper screens approved drugs for SARS-CoV-2 inhibition and finds Fluoxetine significantly inhibits the virus at low concentrations, with no effect on other viruses.

139 citationstop 2%

experimental assaydrug response / drug discovery

𝕏 PostBluesky

Molecular BiologyEBioMedicinePeer-reviewedMar 1, 2021

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity

Markus Hoffmann, Heike Hofmann-Winkler, Joan C. Smith…·Stefan Pöhlmann

This study shows camostat mesylate inhibits SARS-CoV-2 by blocking TMPRSS2 and its metabolite GBPA also has antiviral activity, suggesting no resistance through TMPRSS2-related proteases.

387 citationstop 1%

humanexperimental assay

𝕏 PostBluesky